Natural Beauty Bio-Technology Limited
Natural Beauty Bio-Technology Limited, an investment holding company, provides skin care products and services in Mainland China, Taiwan, and internationally. It manufactures and sells skin care, beauty, aroma-therapeutic, and make-up products, as well as health supplements under the Natural Beauty brand. The company also offers skin treatments, beauty services, medical cosmetology services, and … Read more
Natural Beauty Bio-Technology Limited (NBBTF) - Net Assets
Latest net assets as of June 2025: $484.67 Million USD
Based on the latest financial reports, Natural Beauty Bio-Technology Limited (NBBTF) has net assets worth $484.67 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($851.73 Million) and total liabilities ($367.05 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $484.67 Million |
| % of Total Assets | 56.9% |
| Annual Growth Rate | -0.33% |
| 5-Year Change | -26.77% |
| 10-Year Change | -38.91% |
| Growth Volatility | 14.08 |
Natural Beauty Bio-Technology Limited - Net Assets Trend (2001–2024)
This chart illustrates how Natural Beauty Bio-Technology Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Natural Beauty Bio-Technology Limited (2001–2024)
The table below shows the annual net assets of Natural Beauty Bio-Technology Limited from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $447.59 Million | -22.09% |
| 2023-12-31 | $574.52 Million | -3.84% |
| 2022-12-31 | $597.46 Million | -9.19% |
| 2021-12-31 | $657.92 Million | +7.64% |
| 2020-12-31 | $611.23 Million | +7.65% |
| 2019-12-31 | $567.79 Million | +2.89% |
| 2018-12-31 | $551.86 Million | -15.20% |
| 2017-12-31 | $650.75 Million | -0.60% |
| 2016-12-31 | $654.67 Million | -10.64% |
| 2015-12-31 | $732.63 Million | -5.33% |
| 2014-12-31 | $773.91 Million | -1.82% |
| 2013-12-31 | $788.26 Million | +5.38% |
| 2012-12-31 | $748.00 Million | -5.10% |
| 2011-12-31 | $788.18 Million | +0.71% |
| 2010-12-31 | $782.63 Million | -9.92% |
| 2009-12-31 | $868.83 Million | +1.45% |
| 2008-12-31 | $856.41 Million | -6.47% |
| 2007-12-31 | $915.65 Million | +4.15% |
| 2006-12-31 | $879.17 Million | +7.18% |
| 2005-12-31 | $820.30 Million | +1.95% |
| 2004-12-31 | $804.63 Million | +5.79% |
| 2003-12-31 | $760.59 Million | +0.81% |
| 2002-12-31 | $754.45 Million | +56.33% |
| 2001-12-31 | $482.61 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Natural Beauty Bio-Technology Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 161.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $200.21 Million | 44.73% |
| Other Comprehensive Income | $59.87 Million | 13.38% |
| Other Components | $252.01 Million | 56.30% |
| Total Equity | $447.59 Million | 100.00% |
Natural Beauty Bio-Technology Limited Competitors by Market Cap
The table below lists competitors of Natural Beauty Bio-Technology Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rimbunan Sawit Bhd
KLSE:5113
|
$29.04 Million |
|
Chungdamglobal Co. Ltd.
KQ:362320
|
$29.04 Million |
|
Arcario AB
ST:ARCA
|
$29.05 Million |
|
Starbreeze AB (publ)
PINK:STBEF
|
$29.06 Million |
|
Finnovate Acquisition Corp
NASDAQ:FNVT
|
$29.03 Million |
|
Hi Sharp Electronics Co Ltd
TWO:3128
|
$29.03 Million |
|
Ssangyong Information & Communications Corp
KQ:010280
|
$29.02 Million |
|
Long Time Technology Co., Ltd.
TWO:6555
|
$29.02 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Natural Beauty Bio-Technology Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 574,524,000 to 447,593,000, a change of -126,931,000 (-22.1%).
- Net loss of 103,615,000 reduced equity.
- Other comprehensive income decreased equity by 203,764,001.
- Other factors increased equity by 180,448,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-103.61 Million | -23.15% |
| Other Comprehensive Income | $-203.76 Million | -45.52% |
| Other Changes | $180.45 Million | +40.32% |
| Total Change | $- | -22.09% |
Book Value vs Market Value Analysis
This analysis compares Natural Beauty Bio-Technology Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.26x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $0.30 | $0.06 | x |
| 2002-12-31 | $0.39 | $0.06 | x |
| 2003-12-31 | $0.37 | $0.06 | x |
| 2004-12-31 | $0.40 | $0.06 | x |
| 2005-12-31 | $0.41 | $0.06 | x |
| 2006-12-31 | $0.44 | $0.06 | x |
| 2007-12-31 | $0.45 | $0.06 | x |
| 2008-12-31 | $0.42 | $0.06 | x |
| 2009-12-31 | $0.43 | $0.06 | x |
| 2010-12-31 | $0.39 | $0.06 | x |
| 2011-12-31 | $0.39 | $0.06 | x |
| 2012-12-31 | $0.37 | $0.06 | x |
| 2013-12-31 | $0.39 | $0.06 | x |
| 2014-12-31 | $0.39 | $0.06 | x |
| 2015-12-31 | $0.37 | $0.06 | x |
| 2016-12-31 | $0.33 | $0.06 | x |
| 2017-12-31 | $0.33 | $0.06 | x |
| 2018-12-31 | $0.28 | $0.06 | x |
| 2019-12-31 | $0.28 | $0.06 | x |
| 2020-12-31 | $0.31 | $0.06 | x |
| 2021-12-31 | $0.33 | $0.06 | x |
| 2022-12-31 | $0.30 | $0.06 | x |
| 2023-12-31 | $0.29 | $0.06 | x |
| 2024-12-31 | $0.22 | $0.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Natural Beauty Bio-Technology Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -23.15%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -29.30%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 1.73x
- Recent ROE (-23.15%) is below the historical average (9.24%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 15.64% | 27.91% | 0.39x | 1.43x | $25.61 Million |
| 2002 | 9.05% | 21.70% | 0.36x | 1.17x | $-6.94 Million |
| 2003 | 7.22% | 16.91% | 0.38x | 1.12x | $-20.90 Million |
| 2004 | 7.89% | 17.51% | 0.40x | 1.13x | $-16.77 Million |
| 2005 | 9.96% | 22.63% | 0.38x | 1.15x | $-340.10K |
| 2006 | 13.98% | 33.76% | 0.36x | 1.14x | $34.94 Million |
| 2007 | 19.65% | 39.70% | 0.44x | 1.13x | $87.74 Million |
| 2008 | 28.06% | 40.24% | 0.58x | 1.21x | $153.48 Million |
| 2009 | 17.24% | 27.81% | 0.54x | 1.15x | $62.83 Million |
| 2010 | 4.00% | 6.45% | 0.52x | 1.20x | $-46.95 Million |
| 2011 | 14.61% | 19.47% | 0.62x | 1.22x | $36.32 Million |
| 2012 | 15.94% | 24.67% | 0.55x | 1.18x | $44.45 Million |
| 2013 | 7.39% | 13.26% | 0.45x | 1.25x | $-20.56 Million |
| 2014 | 9.24% | 14.13% | 0.52x | 1.26x | $-5.91 Million |
| 2015 | 18.68% | 26.99% | 0.57x | 1.21x | $63.57 Million |
| 2016 | 22.67% | 31.23% | 0.58x | 1.26x | $82.94 Million |
| 2017 | 16.19% | 26.37% | 0.51x | 1.20x | $40.31 Million |
| 2018 | 4.76% | 7.11% | 0.54x | 1.23x | $-28.93 Million |
| 2019 | 3.86% | 5.00% | 0.57x | 1.35x | $-34.87 Million |
| 2020 | 1.27% | 1.89% | 0.49x | 1.38x | $-53.37 Million |
| 2021 | 5.36% | 7.23% | 0.52x | 1.42x | $-30.53 Million |
| 2022 | -5.10% | -9.07% | 0.38x | 1.48x | $-90.22 Million |
| 2023 | -2.63% | -4.50% | 0.38x | 1.54x | $-72.56 Million |
| 2024 | -23.15% | -29.30% | 0.46x | 1.73x | $-148.37 Million |
Industry Comparison
This section compares Natural Beauty Bio-Technology Limited's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,833,853,398
- Average return on equity (ROE) among peers: 27.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Natural Beauty Bio-Technology Limited (NBBTF) | $484.67 Million | 15.64% | 0.76x | $29.03 Million |
| Acme United Corporation (ACU) | $19.90 Million | 2.51% | 0.55x | $132.86 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $3.02 Billion | 8.59% | 0.75x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.70 Billion | 16.88% | 0.41x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $12.35 Billion | 8.22% | 0.18x | $1.01 Billion |
| Bemax Inc (BMXC) | $-244.86K | 0.00% | 0.00x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $335.48 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $11.97 Million |
| Church & Dwight Company Inc (CHD) | $284.43 Million | 16.52% | 2.34x | $22.97 Billion |
| Colgate-Palmolive Company (CL) | $971.00 Million | 223.07% | 14.49x | $67.85 Billion |